Alnylam Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2011 | $163.9M | $281.9M | $70.2M |
| FY2012 | $153.5M | $287.5M | $51.4M |
| FY2013 | $150.2M | $420.5M | $53.2M |
| FY2014 | $143.3M | $1.08B | $75.2M |
| FY2015 | $121.8M | $1.39B | $180.9M |
| FY2016 | $342.6M | $1.26B | $193.6M |
| FY2017 | $228.3M | $1.99B | $645.4M |
| FY2018 | $272.8M | $1.57B | $420.1M |
| FY2019 | $956.4M | $2.40B | $547.2M |
| FY2020 | $2.39B | $3.41B | $496.6M |